HCW Biologics Inc. Basic Shares Outstanding (Weighted Average)
HCW Biologics Inc. (HCWB) reported Basic Shares Outstanding (Weighted Average) of 1.33 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- HCW Biologics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 1.33M shares, a 347.60% increase year-over-year.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 904.31K shares, a 385.80% increase year-over-year.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 3.41M shares, a 222.14% increase year-over-year.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 2.26M shares, a 139.01% increase year-over-year.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 2.10M shares, a 116.30% increase from fiscal 2024.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 969.83K shares, a 97.30% decline from fiscal 2023.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 35.93M shares, a 0.30% increase from fiscal 2022.
- HCW Biologics Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 35.82M shares, a 90.84% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.33M shares 10-Q · filed 2026-08-14 | 1.12M shares 10-Q · filed 2026-08-14 | 1.88M shares derived: average of 3 quarters · filed 2026-08-14 | 1.97M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 904.31K shares 10-Q/A · filed 2026-08-14 | 5.43M shares 10-Q · filed 2026-05-14 | 2.16M shares derived: average of 2 quarters · filed 2026-08-14 | 2.19M shares derived: average of 3 quarters · filed 2026-08-14 | 1.72M shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | 3.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 2.83M shares derived: average of 2 quarters · filed 2026-03-31 | 1.99M shares derived: average of 3 quarters · filed 2026-08-14 | 2.10M shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 2.26M shares 10-Q · filed 2025-11-14 | 1.28M shares derived: average of 2 quarters · filed 2026-08-14 | 1.66M shares 10-Q · filed 2025-11-14 | 950.11K shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 296.69K shares 10-Q · filed 2026-08-14 | 1.78M shares 10-Q · filed 2025-08-18 | 241.42K shares 10-Q · filed 2026-08-14 | 1.45M shares 10-Q · filed 2025-08-18 | 513.46K shares derived: average of 3 quarters · filed 2026-08-14 | 621.49K shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 186.15K shares 10-Q/A · filed 2026-08-14 | 44.68M shares 10-Q · filed 2025-05-15 | 621.85K shares derived: average of 2 quarters · filed 2026-08-14 | 729.76K shares derived: average of 3 quarters · filed 2026-08-14 | 783.72K shares derived: average of 4 quarters · filed 2026-08-14 | |||
| 2024-12-31 | 1.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 1.00M shares derived: average of 2 quarters · filed 2026-03-31 | 982.90K shares derived: average of 3 quarters · filed 2026-03-31 | 969.83K shares 10-K · filed 2026-03-31 | 38.79M shares 10-K · filed 2025-03-28 | |||
| 2024-09-30 | 945.59K shares 10-Q · filed 2025-11-14 | 37.82M shares 10-Q · filed 2024-11-14 | 945.59K shares derived: average of 2 quarters · filed 2025-11-14 | 940.59K shares 10-Q · filed 2025-11-14 | 37.62M shares 10-Q · filed 2024-11-14 | 18.78M shares derived: average of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | 945.59K shares 10-Q · filed 2025-08-18 | 37.82M shares 10-Q · filed 2024-08-14 | 938.09K shares 10-Q · filed 2025-08-18 | 37.52M shares 10-Q · filed 2024-08-14 | 24.72M shares derived: average of 3 quarters · filed 2025-08-18 | 27.52M shares derived: average of 4 quarters · filed 2025-08-18 | ||
| 2024-03-31 | 37.22M shares 10-Q · filed 2025-05-15 | 36.61M shares derived: average of 2 quarters · filed 2025-05-15 | 36.38M shares derived: average of 3 quarters · filed 2025-05-15 | 36.26M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 36.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 35.96M shares derived: average of 2 quarters · filed 2025-03-28 | 35.94M shares derived: average of 3 quarters · filed 2025-03-28 | 35.93M shares 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | 35.93M shares 10-Q · filed 2024-11-14 | 35.92M shares derived: average of 2 quarters · filed 2024-11-14 | 35.91M shares 10-Q · filed 2024-11-14 | 35.90M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 35.91M shares 10-Q · filed 2024-08-14 | 35.90M shares 10-Q · filed 2024-08-14 | 35.89M shares derived: average of 3 quarters · filed 2024-08-14 | 35.87M shares derived: average of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | 35.88M shares 10-Q · filed 2024-05-15 | 35.87M shares derived: average of 2 quarters · filed 2024-05-15 | 35.86M shares derived: average of 3 quarters · filed 2024-05-15 | 35.85M shares derived: average of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | 35.86M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-15 | 35.85M shares derived: average of 2 quarters · filed 2024-05-15 | 35.84M shares derived: average of 3 quarters · filed 2024-05-15 | 35.82M shares 10-K/A · filed 2024-05-15 | ||||
| 2022-09-30 | 35.84M shares 10-Q · filed 2023-11-14 | 35.82M shares derived: average of 2 quarters · filed 2023-11-14 | 35.81M shares 10-Q · filed 2023-11-14 | 35.79M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 35.81M shares 10-Q · filed 2023-08-11 | 35.80M shares 10-Q · filed 2023-08-11 | 35.78M shares derived: average of 3 quarters · filed 2023-08-11 | 34.23M shares derived: average of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | 35.78M shares 10-Q/A · filed 2023-08-10 | 35.76M shares derived: average of 2 quarters · filed 2023-08-10 | 33.70M shares derived: average of 3 quarters · filed 2023-08-10 | 26.51M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2021-12-31 | 35.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 32.66M shares derived: average of 2 quarters · filed 2023-03-28 | 23.41M shares derived: average of 3 quarters · filed 2023-03-28 | 18.77M shares 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | 29.57M shares 10-Q · filed 2022-11-07 | 17.25M shares derived: average of 2 quarters · filed 2022-11-07 | 13.11M shares 10-Q · filed 2022-11-07 | |||||
| 2021-06-30 | 4.92M shares 10-Q · filed 2022-08-12 | 4.88M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |